1 Beaten-Down Stock to Buy Right Now and Hold for a Decade

President Donald Trump's trade war is creating significant uncertainty. Equities plunged following his decision to impose tariffs on almost every country, then soared after he announced a 90-day pause on his expanded tariff plans. It's challenging to predict which way the market will move next, but in times like these, it helps to invest in companies that look likely to perform well in the long run.Consider the case of TransMedics Group (NASDAQ: TMDX), a medical technology company whose shares have declined by 31% over the past six months. Let's find out why it's worth it to buy this company's shares and hold on to them for the next decade.First, let's review what TransMedics does. The company developed a device called the Organ Care System (OCS) to help store donor organs -- not a simple thing to do. Once they're removed from their natural habitat (the human body), organs deteriorate quickly, making them unusable for transplants. There are already far more patients in need of donor organs than the number of people willing to donate, so keeping the ones that are available in a healthy condition is of the utmost importance.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool